Ireland - English - HPRA (Health Products Regulatory Authority)

teva b.v. - darunavir - film-coated tablet - 600 milligram(s) - protease inhibitors; darunavir

United States - English - NLM (National Library of Medicine)

remedyrepack inc. - darunavir ethanolate (unii: 33o78xf0bw) (darunavir - unii:yo603y8113), cobicistat (unii: lw2e03m5pg) (cobicistat - unii:lw2e03m5pg) - darunavir 800 mg - prezcobix ® is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (hiv-1) infection in treatment-naïve and treatment-experienced adults with no darunavir resistance-associated substitutions (v11i, v32i, l33f, i47v, i50v, i54l, i54m, t74p, l76v, i84v, l89v). prezcobix is contraindicated in patients receiving the following co-administered drugs prezcobix is contraindicated in patients receiving the following co-administered drugs [see drug interactions (7.3) and clinical pharmacology (12.3)]. - alpha 1-adrenoreceptor antagonist: alfuzosin - anticonvulsants: carbamazepine, phenobarbital, phenytoin - anti-gout: colchicine, in patients with renal and/or hepatic impairment - antimycobacterial: rifampin - antipsychotics: lurasidone, pimozide - cardiac disorders: dronedarone, ivabradine, ranolazinecardiac disorders: dronedarone, ivabradine, ranolazine - ergot derivatives, e.g. dihydroergotamine, ergotamine, methylergonovine - gi motility agent: cisapride - he

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - darunavir ethanolate (unii: 33o78xf0bw) (darunavir - unii:yo603y8113) - darunavir 400 mg - prezista® , co-administered with ritonavir (prezista/ritonavir), and with other antiretroviral agents, is indicated for the treatment of human immunodeficiency virus (hiv-1) infection. this indication is based on analyses of plasma hiv-1 rna levels and cd4+ cell counts from 2 controlled phase 3 trials of 48 weeks duration in antiretroviral treatment-naïve and treatment-experienced patients and 2 controlled phase 2 trials of 96 weeks duration in clinically advanced, treatment-experienced adult patients. prezista, co-administered with ritonavir (prezista/ritonavir), and with other antiretroviral agents, is indicated for the treatment of hiv-1 infection in pediatric patients 3 years of age and older [see use in specific populations (8.4) ]. this indication is based on 24-week analyses of plasma hiv-1 rna levels and cd4+ cell counts from 2 open-label phase 2 trials in antiretroviral treatment-experienced pediatric patients (one trial in patients 6 to less than 18 years of age and one trial in patients 3 to less t

United States - English - NLM (National Library of Medicine)

state of florida doh central pharmacy - darunavir ethanolate (unii: 33o78xf0bw) (darunavir - unii:yo603y8113) - darunavir ethanolate 400 mg - prezista® , co-administered with ritonavir (prezista/ritonavir), and with other antiretroviral agents, is indicated for the treatment of human immunodeficiency virus (hiv-1) infection. this indication is based on analyses of plasma hiv rna levels and cd4+ cell counts from 2 controlled phase 3 trials of 48 weeks duration in antiretroviral treatment-naïve and treatment-experienced patients and 2 controlled phase 2 trials of 96 weeks duration in clinically advanced, treatment-experienced adult patients. prezista, co-administered with ritonavir (prezista/ritonavir), and with other antiretroviral agents, is indicated for the treatment of hiv infection in pediatric patients 6 years of age and older [see use in specific populations (8.4) ]. this indication is based on 24-week analyses of plasma hiv rna levels and cd4+ cell counts from an open-label phase 2 trial in antiretroviral treatment-experienced pediatric patients 6 to < 18 years of age. in treatment-experienced adult and pediatric patients, the following poi

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - darunavir - film-coated tablet - 800 milligram(s) - protease inhibitors; darunavir

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

laurus labs limited, india - darunavir - film coated tablet - 600 mg

Uganda - English - National Drug Authority

hetero labs ltd - darunavir - oral solid ordinary tablets - 600 mg

Ireland - English - HPRA (Health Products Regulatory Authority)

clonmel healthcare ltd - darunavir - film-coated tablet - 600 milligram(s) - protease inhibitors; darunavir

Ireland - English - HPRA (Health Products Regulatory Authority)

clonmel healthcare ltd - darunavir - film-coated tablet - 800 milligram(s) - protease inhibitors; darunavir

Ireland - English - HPRA (Health Products Regulatory Authority)

rowex ltd - darunavir - film-coated tablet - 800 milligram(s) - protease inhibitors; darunavir